Polymorphism of Organic Cation Transporter 2 Improves Glucose-Lowering Effect of Metformin via Influencing Its Pharmacokinetics in Chinese Type 2 Diabetic Patients

被引：0
|
作者：
Wolin Hou
Dandan Zhang
Wei Lu
Taishan Zheng
Lili Wan
Qing Li
Yuqian Bao
Fang Liu
Weiping Jia
机构：
[1] Shanghai Jiaotong University Affiliated Sixth People’s Hospital,Department of Endocrinology and Metabolism
[2] Shanghai Clinical Medical Center of Diabetes,Department of Pharmacy
[3] Shanghai Key Clinical Center of Metabolic Diseases,undefined
[4] Shanghai Institute for Diabetes,undefined
[5] Shanghai Key Laboratory of Diabetes,undefined
[6] Shanghai Jiaotong University Affiliated Sixth People’s Hospital,undefined
来源：
Molecular Diagnosis & Therapy | 2015年 / 19卷
关键词：
Metformin; SLC22A2 Gene; Organic Cation Transporter; Glycated Albumin; Baseline HbA1c Level;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 33
页数：8
相关论文
共 50 条
  • [41] Blood glucose-lowering effect of Tectona grandis flowers in type 2 diabetic rats: A study on identification of active constituents and mechanisms for antidiabetic action
    Ramachandran, Subramaniam
    Rajasekaran, Aiyalu
    JOURNAL OF DIABETES, 2014, 6 (05) : 427 - 437
  • [42] The effect of nateglinide combined with metformin on the repairment of abnormal glucose tolerance in new-onset type 2 diabetic patients and its mechanisms
    Chang, B. -C.
    Zheng, M. -Y.
    Chen, L. -M.
    DIABETOLOGIA, 2009, 52 : S354 - S354
  • [43] Does the Glucose-Lowering Action of Omarigliptin, a Weekly DPP-4 Inhibitor, Last over a Week in Japanese Type 2 Diabetic Patients?
    Taniguchi, Yukiko
    Onishi, Tetsuro
    Mori, Yutaka
    DIABETES, 2017, 66 : A325 - A325
  • [44] Ablation of Both Organic Cation Transporter (Oct)1 and Oct2 Alters Metformin Pharmacokinetics but Has No Effect on Tissue Drug Exposure and Pharmacodynamics
    Higgins, J. William
    Bedwell, David W.
    Zamek-Gliszczynski, Maciej J.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (06) : 1170 - 1177
  • [45] Rosiglitazone (BRL49653) monotherapy has significant glucose lowering effect in type 2 diabetic patients
    Patel, J
    Miller, E
    Patwardhan, R
    DIABETES, 1998, 47 : A17 - A17
  • [46] The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1
    Nerild, H. H.
    Bronden, A.
    Haddouchi, A. E.
    Holst, J. J.
    Sonne, D. P.
    Vilsboll, T.
    Knop, F. K.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 217 - 217
  • [47] Initiation of glucose-lowering drugs reduces the anticoagulant effect of warfarin-But not through altered drug metabolism in patients with type 2 diabetes
    Dunvald, Ann-Cathrine Dalgard
    Nielsen, Flemming
    Olsen, Dorte Aalund
    Ernst, Martin Thomsen
    Donnelly, Louise
    Soto-Pedre, Enrique
    Kristiansen, Maja Refshauge
    Nielsen, Jens Steen
    Persson, Frederik
    Hojlund, Kurt
    Madsen, Jonna Skov
    Sondergaard, Jens
    Pearson, Ewan
    Pottegard, Anton
    Stage, Tore Bjerregaard
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (08) : 2529 - 2541
  • [48] The acute glucose-lowering effect of metfomin in patients with type 2 diabetes is partly glucagon-like peptide-1-dependent
    Hansen, M.
    Bahne, E.
    Sonne, D. P.
    Rehfeld, J. F.
    Holst, J. J.
    Vilsboll, T.
    Knop, F. K.
    DIABETOLOGIA, 2015, 58 : S110 - S110
  • [49] The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin
    Kashi, Zahra
    Masoumi, Parisa
    Mahrooz, Abdolkarim
    Hashemi-Soteh, Mohammad Bagher
    Bahar, Adele
    Alizadeh, Ahad
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (01) : 78 - 83
  • [50] DAPAGLIFLOZIN ATTENUATES DIABETIC CARDIOMYOPATHY AND THE ACTIVATION OF THE NLRP3/ASC INFLAMMASOME IN MICE WITH TYPE-2 DIABETES: A GLUCOSE-LOWERING AND SGLT-2 INDEPENDENT EFFECT
    Ye, Yumei
    Bajaj, Mandeep
    Birnbaum, Yochai
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 752 - 752
12345